Clinical Trial Update: Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.

View source ↗

Summary

This clinical trial update reports on the effects of six months of pioglitazone treatment on HbA1c levels in individuals with diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Status: COMPLETED